Chih-Hung Chuang

644 total citations
34 papers, 479 citations indexed

About

Chih-Hung Chuang is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Chih-Hung Chuang has authored 34 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Oncology. Recurrent topics in Chih-Hung Chuang's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Glycosylation and Glycoproteins Research (5 papers) and Protein purification and stability (5 papers). Chih-Hung Chuang is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Glycosylation and Glycoproteins Research (5 papers) and Protein purification and stability (5 papers). Chih-Hung Chuang collaborates with scholars based in Taiwan, China and Vietnam. Chih-Hung Chuang's co-authors include Tian‐Lu Cheng, Yun‐Chi Lu, Wen-Wei Lin, Ta-Chun Cheng, Yi‐Ping Fang, Steve R. Roffler, Yuan-Chin Hsieh, Kuo‐Hsiang Chuang, Yeng‐Tseng Wang and Shey-Cherng Tzou and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Analytical Chemistry.

In The Last Decade

Chih-Hung Chuang

34 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chih-Hung Chuang Taiwan 13 253 96 96 93 86 34 479
Marco Cavaco Portugal 13 290 1.1× 47 0.5× 89 0.9× 81 0.9× 94 1.1× 28 498
Ta-Chun Cheng Taiwan 15 418 1.7× 122 1.3× 117 1.2× 104 1.1× 145 1.7× 23 670
Seetharama D. Satyanarayanajois United States 17 323 1.3× 76 0.8× 165 1.7× 133 1.4× 42 0.5× 29 658
Georges Da Violante France 7 388 1.5× 71 0.7× 60 0.6× 192 2.1× 40 0.5× 9 812
Christine Wurth Switzerland 13 537 2.1× 61 0.6× 105 1.1× 68 0.7× 43 0.5× 18 744
Mridula Misra India 9 162 0.6× 61 0.6× 88 0.9× 66 0.7× 95 1.1× 20 403
Maxim Antopolsky Finland 15 421 1.7× 36 0.4× 89 0.9× 62 0.7× 36 0.4× 26 665
Xing Q. Pan United States 11 293 1.2× 87 0.9× 96 1.0× 60 0.6× 193 2.2× 15 543
Charles Wartchow United States 12 470 1.9× 119 1.2× 104 1.1× 63 0.7× 77 0.9× 18 747

Countries citing papers authored by Chih-Hung Chuang

Since Specialization
Citations

This map shows the geographic impact of Chih-Hung Chuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih-Hung Chuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih-Hung Chuang more than expected).

Fields of papers citing papers by Chih-Hung Chuang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chih-Hung Chuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih-Hung Chuang. The network helps show where Chih-Hung Chuang may publish in the future.

Co-authorship network of co-authors of Chih-Hung Chuang

This figure shows the co-authorship network connecting the top 25 collaborators of Chih-Hung Chuang. A scholar is included among the top collaborators of Chih-Hung Chuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chih-Hung Chuang. Chih-Hung Chuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yen-Ling, Chiao-Yun Chen, Benjamin G. Wu, et al.. (2025). Development of a tumor-region-selective activation monoclonal antibody targeting the 4-1BB receptor for enhanced therapeutic efficacy and safety. International Journal of Biological Macromolecules. 305(Pt 2). 141003–141003. 1 indexed citations
2.
Chien, Shang‐Tao, et al.. (2024). Maximizing oxaliplatin's impact on EGFR + colorectal cancer through targeted extracellular vesicles. Cancer Nanotechnology. 15(1). 1 indexed citations
3.
Cheng, Tian‐Lu, et al.. (2024). Exploring the therapeutic potential of DV-B-120 as an inhibitor of dengue virus infection. Journal of Virology. 98(4). e0125823–e0125823. 3 indexed citations
4.
Chen, C. Y., et al.. (2023). Anti-Covid-19 Activity Compounds from Michelia crassipes. Chemistry of Natural Compounds. 59(2). 371–373. 12 indexed citations
5.
Huang, Ming‐Yii, Tian‐Lu Cheng, Chien‐Chih Ke, et al.. (2023). XPF–ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer. Cells. 12(11). 1475–1475. 3 indexed citations
6.
Lin, Wen‐Wei, Yeng‐Tseng Wang, Chien‐Shu Chen, et al.. (2023). Development of NS2B-NS3 protease inhibitor that impairs Zika virus replication. Virus Research. 329. 199092–199092. 5 indexed citations
7.
Cheng, Kai-Wen, Chih-Hua Tseng, I‐Ju Chen, et al.. (2022). Inhibition of gut microbial β-glucuronidase effectively prevents carcinogen-induced microbial dysbiosis and intestinal tumorigenesis. Pharmacological Research. 177. 106115–106115. 18 indexed citations
8.
Chuang, Chih-Hung, Tian‐Lu Cheng, Wei‐Chun Chen, et al.. (2022). Micro-PET imaging of hepatitis C virus NS3/4A protease activity using a protease-activatable retention probe. Frontiers in Microbiology. 13. 896588–896588. 1 indexed citations
9.
Chen, Yi‐Ting, Chun‐Ming Huang, Chien‐Chih Ke, et al.. (2022). HIF-1α Expression Increases Preoperative Concurrent Chemoradiotherapy Resistance in Hyperglycemic Rectal Cancer. Cancers. 14(16). 4053–4053. 6 indexed citations
10.
Huang, Ming‐Yii, Tian‐Lu Cheng, Chien‐Chih Ke, et al.. (2022). ERCC1 Overexpression Increases Radioresistance in Colorectal Cancer Cells. Cancers. 14(19). 4798–4798. 5 indexed citations
11.
Cheng, C. C., et al.. (2022). Evaluation of Clove Extract for Drug Therapy of Ciliate Infection in Coral (Goniopora columna). Biology. 11(2). 280–280. 5 indexed citations
12.
Lin, Wen-Wei, Yun‐Chi Lu, Chih-Hung Chuang, et al.. (2021). Selective activation of pro-anti-IL-1β antibody enhances specificity for autoinflammatory disorder therapy. Scientific Reports. 11(1). 14846–14846. 10 indexed citations
13.
Lin, Wen-Wei, Yun‐Chi Lu, Chih-Hung Chuang, & Tian‐Lu Cheng. (2020). Ab locks for improving the selectivity and safety of antibody drugs. Journal of Biomedical Science. 27(1). 76–76. 30 indexed citations
14.
Chen, I‐Ju, Yi‐An Cheng, Wen-Wei Lin, et al.. (2020). Bispecific antibody (HER2 × mPEG) enhances anti-cancer effects by precise targeting and accumulation of mPEGylated liposomes. Acta Biomaterialia. 111. 386–397. 21 indexed citations
15.
Lu, Yun‐Chi, Chih-Hung Chuang, Kuo‐Hsiang Chuang, et al.. (2019). Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy. PLoS Biology. 17(6). e3000286–e3000286. 26 indexed citations
16.
Huang, Hui-Wen, Chufeng Wang, Po‐Liang Lu, et al.. (2018). Evolutionary histories of coxsackievirus B5 and swine vesicular disease virus reconstructed by phylodynamic and sequence variation analyses. Scientific Reports. 8(1). 8821–8821. 6 indexed citations
17.
Fang, Yi‐Ping, et al.. (2018). SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study. International Journal of Nanomedicine. Volume 13. 2789–2802. 33 indexed citations
18.
Lin, Wen-Wei, I‐Ju Chen, Ta-Chun Cheng, et al.. (2016). A Secondary Antibody-Detecting Molecular Weight Marker with Mouse and Rabbit IgG Fc Linear Epitopes for Western Blot Analysis. PLoS ONE. 11(8). e0160418–e0160418. 10 indexed citations
19.
Kuo, Kung‐Kai, Ta-Chun Cheng, Chih-Hung Chuang, et al.. (2015). Development of Membrane-Bound GM-CSF and IL-18 as an Effective Tumor Vaccine. PLoS ONE. 10(7). e0133470–e0133470. 5 indexed citations
20.
Chuang, Kuo‐Hsiang, Yuan-Chin Hsieh, Chih-Hung Chuang, et al.. (2014). High-Throughput Sorting of the Highest Producing Cell via a Transiently Protein-Anchored System. PLoS ONE. 9(7). e102569–e102569. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marco Cavaco Breakdown of academic impact, for papers by Ta-Chun Cheng Breakdown of academic impact, for papers by Seetharama D. Satyanarayanajois Breakdown of academic impact, for papers by Georges Da Violante Breakdown of academic impact, for papers by Christine Wurth Breakdown of academic impact, for papers by Mridula Misra Breakdown of academic impact, for papers by Maxim Antopolsky Breakdown of academic impact, for papers by Xing Q. Pan Breakdown of academic impact, for papers by Charles Wartchow
Rankless by CCL
2026